Free · no account · quoted from the filing

What changed in RPRX's 10-Q

Source: 10-Q filed 2026-05-06 · compared against 10-Q 2025-11-05. Every passage below is quoted verbatim from the filing itself.

Corporate structure

This filing

We completed the acquisition of RP Manager on May 16, 2025 and accounted for the transaction as a business combination

Accounting standards

This filing

we concluded that the CK-586 funding arrangement qualifies for the derivative scope exception. Accordingly, we recorded a $12.0 million cumulative-effect adjustment to the opening balance of retained earnings

Interest expense

This filing

Interest expense increased by $28.5 million, or 43.6%, in the first quarter of 2026 as compared to the first quarter of 2025

Portfolio

This filing

royalties on more than 35 commercial products, including...Amgen's Imdelltra and Alnylam's Amvuttra, among others, and 19 development-stage product candidates

Risk factors

This filing

our use of leverage; our ability to leverage our competitive strengths and to realize the benefits of our 2025 internalization of our manager

What it means — the analyst reading

The passages above are the company's own words. The plain-English reading of them — what changed, why it matters, and the direction of travel, plus 2 further changes without a quotable passage — is part of the Filing Change Monitor.

See the Filing Change Monitor →

Compared from narrative excerpts (outlook, risks, MD&A) of both filings — quotes are verbatim from the new filing. Not advice. Source: company SEC filings via stockportfolio.pro. Educational, not investment advice.